Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank43
Studio
Year-over-Year Change

Free cash flow yield

Latest
-20.21%
↑ 74% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-78.33%
Historical baseline
PeriodValueYoY Change
2025-20.21%-10.7%
2024-18.27%+61.6%
2023-47.59%+16.3%
2022-56.87%-473.9%
2021-9.91%-125.2%
2020-4.40%+97.6%
2019-180.03%-1.0%
2018-178.21%+18.1%
2017-217.48%-332.5%
2016-50.28%-